A detailed history of Globalt Investments LLC / Ga transactions in United Therapeutics Corp stock. As of the latest transaction made, Globalt Investments LLC / Ga holds 900 shares of UTHR stock, worth $323,622. This represents 0.01% of its overall portfolio holdings.

Number of Shares
900
Previous 900 -0.0%
Holding current value
$323,622
Previous $287 Million 12.49%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $205,434 - $287,136
900 New
900 $287 Million
Q1 2024

May 01, 2024

BUY
$210.76 - $249.51 $189,684 - $224,559
900 New
900 $207 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Globalt Investments LLC / Ga Portfolio

Follow Globalt Investments LLC / Ga and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globalt Investments LLC / Ga, based on Form 13F filings with the SEC.

News

Stay updated on Globalt Investments LLC / Ga with notifications on news.